Ono Pharmaceutical (OTCMKTS:OPHLF - Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.21 earnings per share for the quarter, Zacks reports. Ono Pharmaceutical had a net margin of 19.64% and a return on equity of 11.85%.
Ono Pharmaceutical Price Performance
Shares of OPHLF stock remained flat at $10.18 during trading on Thursday. 5,400 shares of the company traded hands, compared to its average volume of 5,230. The business's 50 day simple moving average is $10.29 and its 200-day simple moving average is $12.41. The firm has a market cap of $4.78 billion, a PE ratio of 7.59 and a beta of 0.59. The company has a quick ratio of 2.80, a current ratio of 3.22 and a debt-to-equity ratio of 0.15. Ono Pharmaceutical has a one year low of $9.22 and a one year high of $16.82.
Ono Pharmaceutical Company Profile
(
Get Free Report)
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Read More
Before you consider Ono Pharmaceutical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ono Pharmaceutical wasn't on the list.
While Ono Pharmaceutical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
